Resnick, Chodorow & Associates wrote a white paper on digital technology-enabled care models for diabetes for the National Committee for Quality Assurance. Click here to read the white paper.
Resnick, Chodorow & Associates was responsible for the systematic literature review, abstract review, and evidence synthesis for an ISTH clinical practice guideline for antithrombotic treatment in COVID-19.
Click here to read the practice guideline.
Resnick, Chodorow & Associates provided scientific writing and editorial support to the National Committee for Quality Assurance on an article describing barriers and facilitators of collecting data on social determinants of health. Click here to read the article.
Resnick, Chodorow & Associates wrote a white paper on nonalcoholic fatty liver disease for the National Committee for Quality Assurance. Click here to read the white paper.
Resnick, Chodorow & Associates wrote a white paper on COVID-19 vaccine hesitancy to support efforts of the GTMRx Institute's National Taskforce on Building Vaccine Confidence in the Medical Neighborhood.
Click here to read the report.
Resnick, Chodorow & Associates wrote a white paper on quality of care for patients with type 2 diabetes and heart failure for the National Committee for Quality Assurance. Click here to read the report.
Resnick, Chodorow & Associates researched and wrote issue briefs for the Patient Access Network Foundation on the topic of cost-sharing for prescription medications. Click here to read the briefs.
Resnick, Chodorow & Associates provided methodological and scientific writing support the American Cleft Palate Craniofacial Association on the update to its Parameters of Care for Individuals with Cleft/Lip and/or Palate. Click here to read the Parameters of Care.
Resnick, Chodorow & Associates provided methodological and scientific writing support for America's Physician Groups on a case series that featured innovation in value-based care. Click here to read the case series.
Resnick, Chodorow & Associates wrote a white paper for PhRMA on disparities in medication access and adherence. Click here to read the white paper.
Resnick, Chodorow & Associates co-authored an article with the National Committee for Quality Assurance on development of a core measure set for age-friendly health care delivery. Click here to read the article.
Resnick, Chodorow & Associates supported the HIV Medicine Association of the Infectious Diseases Society of America to update primary care guidance for people with HIV. Click here
to read the guideline.
Resnick, Chodorow & Associates co-authored an article on the impact of FGFR gene alterations on clinical outcomes in urothelial cancer. Click here to read the article.
Resnick, Chodorow & Associates supported the Endocrine Society on a report addressing the importance of prioritizing patient experiences in diabetes care. Click here to read the report.
Resnick, Chodorow & Associates supported the American Academy of Otolaryngic Allergy to produce an evidence review of clinical trial data that led to regulatory approval of biologic agents for treatment of conditions that are relevant to otolaryngology and allergy.
Click here to read the review.
Resnick, Chodorow & Associates supported PhRMA on research addressing the importance of small molecule medicines. Click here to read the article.
Resnick, Chodorow & Associates supported PC Project to develop a research agenda. Click here to read the research Agenda.
Resnick, Chodorow & Associates provided methodologic expertise and writing support to develop a Research Agenda for the American Society of Parenteral and Enteral Nutrition. Click here to read the article.
Resnick, Chodorow & Associates was responsible for the systematic literature review and meta analysis for a Cystic Fibrosis Foundation clinical practice guideline on CFTR modulators. Click here to read the guideline.
Resnick, Chodorow & Associates was responsible for the systematic literature review, abstract review, and evidence synthesis for a Cystic Fibrosis Foundation clinical practice guideline on treatment of sinonasal disease among people with cystic fibrosis. Click here to read the practice guideline.
Resnick, Chodorow & Associates provided methodologic expertise on a systematic review of the literature on microscopic hematuria screening for the American Urogynecologic Society. Click here to read the review.
Resnick, Chodorow & Associates supported the American Academy of Otolaryngic Allergy to produce an evidence review of clinical trial data that led to regulatory approval of biologic agents for treatment of conditions that are relevant to otolaryngology and allergy.
Click here to read the review.
Resnick, Chodorow & Associates wrote a meeting summary on public trust in science for the National Academies of Science, Engineering, and Medicine. Click here to read the proceedings report.
Resnick, Chodorow & Associates co-authored a review article on provider behavior and treatment intensification in diabetes care. Click here to read the article.
Resnick, Chodorow & Associates co-authored an article on charitable assistance among economically vulnerable cancer patients. Click here to read the article.
Resnick, Chodorow & Associates edited a report on the science, ethics, and governance of human genome editing for the National Academies of Science, Engineering, and Medicine. Click here to read the report.
Resnick, Chodorow & Associates conducted statistical analysis and co-authored a report on malnutrition diagnoses in hospitalized patients for the American Society of Parenteral and Enteral Nutrition. Click here to read the article.
Resnick, Chodorow & Associates provided research and editorial support for a scientific statement on postoperative opioid prescribing for the American Urogynecologic Society. Click here to read the statement.
Resnick, Chodorow & Associates provided research design and methodologic support to NORC at the University of Chicago to identify research design options for the Long-Term Care Ombudsman Program. Click here to read the report.
Resnick, Chodorow & Associates provided research design and methodologic and writing support to NORC at the University of Chicago for a process evaluation of the Long-Term Care Ombudsman Program. Click here to read the report.
Resnick, Chodorow & Associates provided research design and methodologic and writing support to NORC at the University of Chicago for a report on the changing landscape of the Long-Term Care Ombudsman Program. Click here to read the report.
Resnick, Chodorow & Associates wrote a proceedings report on health equity for women and birthing people for the Association of American Medical Colleges Center for Health Justice. Click here to read the report.